HealthCor Management’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-72,020
| Closed | -$7.57M | – | 72 |
|
|
2022
Q2 | $7.57M | Buy |
+72,020
| New | +$8.54M | 0.76% | 34 |
|
|
2021
Q4 | – | Sell |
-340,508
| Closed | -$48.4M | – | 88 |
|
|
2021
Q3 | $48.4M | Sell |
340,508
-446,752
| -57% | -$65.7M | 2.09% | 20 |
|
|
2021
Q2 | $123M | Buy |
787,260
+4,790
| +0.6% | +$776K | 4.91% | 1 |
|
|
2021
Q1 | $122M | Buy |
782,470
+214,544
| +38% | +$33.2M | 4.3% | 3 |
|
|
2020
Q4 | $85M | Sell |
567,926
-777,429
| -58% | -$110M | 3.28% | 11 |
|
|
2020
Q3 | $178M | Buy |
1,345,355
+1,141,054
| +559% | +$149M | 7.12% | 1 |
|
|
2020
Q2 | $23.7M | Sell |
204,301
-644,646
| -76% | -$74.3M | 0.99% | 31 |
|
|
2020
Q1 | $83.3M | Buy |
848,947
+388,525
| +84% | +$50.9M | 3.56% | 10 |
|
|
2019
Q4 | $66.9M | Sell |
460,422
-284,649
| -38% | -$39.3M | 2.39% | 14 |
|
|
2019
Q3 | $99.3M | Buy |
+745,071
| New | +$96.2M | 3.75% | 7 |
|
|
2019
Q2 | – | Sell |
-1,095,086
| Closed | -$136M | – | 66 |
|
|
2019
Q1 | $136M | Buy |
1,095,086
+843,564
| +335% | +$95.9M | 5.49% | 3 |
|
|
2018
Q4 | $25.3M | Sell |
251,522
-1,937,228
| -89% | -$218M | 0.79% | 32 |
|
|
2018
Q3 | $279M | Buy |
2,188,750
+206,000
| +10% | +$24.5M | 9.27% | 1 |
|
|
2018
Q2 | $215M | Sell |
1,982,750
-412,000
| -17% | -$44.8M | 6.81% | 3 |
|
|
2018
Q1 | $254M | Buy |
2,394,750
+824,000
| +52% | +$95.7M | 8.62% | 1 |
|
|
2017
Q4 | $184M | Sell |
1,570,750
-172,844
| -10% | -$19.5M | 5.99% | 3 |
|
|
2017
Q3 | $198M | Buy |
1,743,594
+1,220,941
| +234% | +$141M | 6.64% | 4 |
|
|
2017
Q2 | $65.2M | Buy |
+522,653
| New | +$62M | 2.35% | 16 |
|
|
2017
Q1 | – | Sell |
-695,003
| Closed | -$69.6M | – | 48 |
|
|
2016
Q4 | $69.6M | Sell |
695,003
-386,497
| -36% | -$41.4M | 3.94% | 9 |
|
|
2016
Q3 | $137M | Buy |
1,081,500
+51,500
| +5% | +$6.36M | 8.32% | 1 |
|
|
2016
Q2 | $120M | Sell |
1,030,000
-515,000
| -33% | -$58.3M | 6.57% | 5 |
|
|
2016
Q1 | $160M | Buy |
1,545,000
+618,000
| +67% | +$59.8M | 9.06% | 1 |
|
|
2015
Q4 | $92.3M | Buy |
+927,000
| New | +$90.7M | 5.61% | 6 |
|
|
2015
Q1 | – | Sell |
-272,332
| Closed | -$30M | – | 77 |
|
|
2014
Q4 | $30M | Buy |
+272,332
| New | +$28.7M | 1.67% | 27 |
|
|
2014
Q1 | – | Sell |
-52,221
| Closed | -$4.72M | – | 71 |
|
|
2013
Q4 | $4.72M | Sell |
52,221
-900,529
| -95% | -$77.9M | 0.29% | 44 |
|
|
2013
Q3 | $76M | Buy |
+952,750
| New | +$75M | 4.07% | 7 |
|
Other funds holding ZBH
HealthCor Management's ZBH Position: Q3 2022 in Review
HealthCor Management sold out of Zimmer Biomet (ZBH) in Q3 2022, closing a stake of 72,020 shares — an estimated $7.57M sold.
HealthCor Management first reported a position in ZBH in Q3 2013 and held it in 26 quarters. The position peaked at $279M in Q3 2018. 919 funds tracked by Wall St. Rank hold ZBH as of Q3 2022.
- HealthCor Management reported no remaining Zimmer Biomet position as of Q3 2022 after selling out during the quarter.
- HealthCor Management sold 72,020 Zimmer Biomet shares in Q3 2022, an estimated $7.57M.
- HealthCor Management first reported a position in Zimmer Biomet in Q3 2013 and held it in 26 quarters.
- HealthCor Management's Zimmer Biomet position peaked at $279M in Q3 2018.
- 919 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2022.
Based on HealthCor Management's 13F filing for Q3 2022, filed 14 Nov 2022.